Dr. Rousseau has served as Milestone’s Vice President of Regulatory Affairs and Quality Assurance since 2016 with responsibilities to lead global regulatory affairs. Dr. Rousseau brings over 30 years of international experience in regulatory affairs and in global drug development.
Mr. Pimplaskar has served as Milestone’s Vice President of Chemistry, Manufacturing and Controls since 2018. He brings 25 years of experience in CMC, pharmaceutical development, clinical manufacturing and technology transfer to his role as head of CMC for global drug development of Milestone’s cardiovascular programs.
Mr. Nelson has served as Milestone’s Vice President of Program Management since 2018. He has over 15 years of experience in the pharmaceutical and biotech field, working primarily in project management, clinical operations, regulatory affairs, and public finance.
Mr. Muller has served as Milestone’s Chief Commercial Officer since October 2017. Mr. Muller has almost 30 years of pharmaceutical industry experience where he served startup-to-large multinational companies.